Media Center

  PRESS RELEASE
August 19, 2019

Morphe Holdings and General Atlantic Announce Partnership and Strategic Growth Investment

Morphe Holdings, a global beauty company, and General Atlantic, a leading global growth equity firm, announced today the launch of a new partnership in which General Atlantic will acquire a majority stake in the company alongside existing investor Summit Partners and co-founders Chris and Linda Tawil. Additional terms of the deal were not disclosed.

  PRESS RELEASE
August 15, 2019

Motif Ingredients Rebrands to Motif FoodWorks, Raises $27.5 Million to Fuel Animal-Free Ingredients R&D

Ingredients innovation company, Motif Ingredients, today announced it received $27.5 million in funding led by General Atlantic, a leading global growth equity firm, with participation from CPT Capital. The company also revealed a new brand identity and name, Motif FoodWorks, and announced a number of additions to its leadership team. The capital raise, evolution of its brand and expanded team strategically position Motif FoodWorks to fulfill its aspiration to extend the realm of what’s possible with animal-free ingredients.

  PRESS RELEASE
August 1, 2019

Wish Valuation Rises to More Than $11 Billion Following Series H Financing Led by General Atlantic

Mobile shopping leader Wish today announced that the company’s valuation was $11.2 billion post-money following a Series H round of financing led by General Atlantic, a leading global growth equity firm. With this new investment, Wish’s valuation increased from $8.7 billion following its last funding round in late 2017.

  PRESS RELEASE
July 8, 2019

Vittorio Colao Joins General Atlantic as Special Advisor

General Atlantic, a leading global growth equity firm, announced today that Vittorio Colao has joined the firm as a Special Advisor. Mr. Colao, former Group Chief Executive of international communications company Vodafone Group Plc, will advise General Atlantic and its portfolio companies as the firm continues to execute on its global growth investing strategy.

  PRESS RELEASE
June 26, 2019

Detroit-based StockX Closes $110M Series C Led by DST Global, General Atlantic and GGV Capital; Names e-commerce Veteran Scott Cutler CEO

StockX, the world’s first ‘stock market of things’, has closed on a $110 million Series C funding round from investment firms DST Global, General Atlantic, and GGV Capital. The company also announced today the appointment of Scott Cutler as CEO. Cutler succeeds co-founder Josh Luber, who will continue to serve on the executive leadership team and board of directors. The raise, in which current investors GV and Battery Ventures also participated, represents the largest in Michigan VC history to date and values StockX at over $1 billion.

  PRESS RELEASE
June 24, 2019

Blend Raises $130 Million in Series E Funding to Power One-Tap Mortgages and Consumer Loans

Blend, a leader in digital lending technology, today announced it has raised $130 million in Series E funding led by Temasek and General Atlantic. Existing investors 8VC, Founders Fund, Greylock Partners, and Lightspeed Venture Partners also participated in the round, which brings the company’s total funding to $310 million.

  PRESS RELEASE
May 15, 2019

Nobel Laureate Economist Michael Spence Joins General Atlantic as Special Advisor

General Atlantic, a leading global growth equity firm, announced today that world-renowned economist and Nobel Laureate Michael Spence has joined the firm as a Special Advisor.

  PRESS RELEASE
April 17, 2019

PathAI Secures $60M in Series B Funding Led by General Atlantic and Existing Investor General Catalyst

PathAI, a global provider of artificial intelligence-powered technology for pathology, announced today that it has raised $60 million in Series B funding. The round was led by new investor General Atlantic, a leading global growth equity firm, with strong participation from General Catalyst and other existing investors. The new capital will fuel PathAI’s continued expansion as the company seeks to advance the medical discipline of pathology. General Atlantic Managing Director Dr. Michelle Dipp will be joining PathAI’s board of directors as the company advances its mission of offering faster, safer, and more powerful solutions for the diagnosis and sub-typing of diseases like cancer.

  PRESS RELEASE
April 15, 2019

Michael Gosk Joins General Atlantic as Operating Partner

General Atlantic, a leading global growth equity firm, announced today that Michael Gosk, former Vice President and Chief Tax Officer at General Electric (“GE”) has joined the firm as an Operating Partner.  Based in New York, Mr. Gosk will provide expertise and strategic counsel to the firm’s investment team and portfolio companies, with a particular focus on financial operations and tax.

  PRESS RELEASE
January 9, 2019

Justin Kotzin Joins General Atlantic as Operating Partner and Head of Debt Capital Markets

General Atlantic, a leading global growth equity firm, announced today that Justin Kotzin has joined the firm as an Operating Partner and Head of Debt Capital Markets. Based in New York, Mr. Kotzin will be part of General Atlantic’s Resources Group, providing expertise and strategic counsel to the firm’s investment teams and portfolio companies.

  PRESS RELEASE
January 7, 2019

Advent International to acquire majority stake in leading third-party hotel operator Aimbridge Hospitality

Advent International, one of the largest and most experienced global private equity investors, today announced that it has signed a definitive agreement to acquire a majority ownership interest in North America’s leading third-party hotel operator Aimbridge Hospitality from Lee Equity Partners, a U.S.-based private equity firm, and General Atlantic, a leader in global growth investing. Aimbridge’s experienced senior management team will continue to lead the company and will retain a meaningful equity stake in the business.

  PRESS RELEASE
January 7, 2019

Rob Perez Joins General Atlantic as Operating Partner to Bolster Life Sciences Practice

General Atlantic, a leading global growth equity firm, announced today that Rob Perez, former President and CEO of Cubist Pharmaceuticals, Inc. has joined the firm as an Operating Partner. Based in the firm’s New York office, Mr. Perez will have a particular focus on the biopharma and life sciences sectors, using his expertise to identify new investment opportunities and support the growth of the firm’s existing investments. Mr. Perez will be a part of the General Atlantic’s Resources Group, providing strategic counsel to the firm’s investment teams and portfolio companies.

MEDIA CONTACTS

 

Mary Armstrong

+1 646 710 5626

media@generalatlantic.com